Zoetis Inc. (ETR:ZOE)
Germany · Delayed Price · Currency is EUR | Market Cap | 46.96B |
| Revenue (ttm) | 8.01B |
| Net Income (ttm) | 2.26B |
| Shares Out | n/a |
| EPS (ttm) | 5.06 |
| PE Ratio | 20.79 |
| Forward PE | 19.11 |
| Dividend | 1.78 (1.71%) |
| Ex-Dividend Date | Oct 31, 2025 |
| Volume | 462 |
| Average Volume | 1,388 |
| Open | 105.20 |
| Previous Close | 104.40 |
| Day's Range | 104.12 - 105.60 |
| 52-Week Range | 97.50 - 170.22 |
| Beta | 0.97 |
| RSI | 44.48 |
| Earnings Date | Feb 13, 2026 |
About Zoetis
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]
Full Company ProfileFinancial Performance
In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.
Financial numbers in USD Financial StatementsNews
Trade Tracker: Stephanie Link buys mores Zoetis
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.
Trade Tracker: Stephanie Link buys mores Zoetis
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to explain why she's buying more Zoetis.
Zoetis (ZTS) Outperforms Broader Market: What You Need to Know
Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day.
Warren Buffett Detailed Fundamental Analysis - ZTS
Below is Validea's guru fundamental report for ZOETIS INC (ZTS). Of the 22 guru strategies we follow, ZTS rates highest using our Patient Investor model based on the published strategy of Warren Buffe...
Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows.
Figma, Pinterest, and Zoetis are struggling this year due to a combination of high valuations and disappointing earnings. However, they possess some attractive long-term growth opportunities.
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Kristin Peck, Chief ...
These 2 Healthcare Stocks Just Declared Dividend Raises
One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space.
4 Stocks That Declared Dividend Hikes Amid Ongoing Economic Uncertainty
CNP, VAC, PCG and ZTS raised dividends as tech volatility and economic uncertainty push income-focused investors toward steadier stocks.
Zoetis (ZTS) Launches $1.75 Billion Convertible Notes Offering
Zoetis (ZTS) Launches $1.75 Billion Convertible Notes Offering
Zoetis prices $1.75 billion convertible senior notes
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggr...
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market conditions, it intends to offer $1.75 billion aggr...
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Gabelli Pet Parents' Fund’s Q3’s largest contributors included Chewy Inc., Zoetis Inc., and Freshpet Inc. Largest detractors were Trupanion Inc., Petco Health & Wellness, and CVS Group plc.
Daily Dividend Report: ABT,ZTS,EQR,PM,AMAT
Abbott today announced that its board of directors has increased the company's quarterly common dividend to 63 cents per share, an increase of 6.8%. The company's quarterly dividend payout has increas...
Zoetis raises dividend by 6% to $0.53
Zoetis Inc. (ZTS) Announces First Quarter 2026 Dividend
Zoetis Inc. (ZTS) Announces First Quarter 2026 Dividend
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.53 per share for the first quarter of 2026, an increase of 6% f...
Professor Tim Spector's daily routine: meditating, saunas and plenty of time off
The Zoe co-founder begins his morning with exercise and black coffee, meditates twice a day and times his meals religiously
Zoetis (ZTS) Receives 'Equal-Weight' Rating from Barclays with a $136 Target | ZTS Stock News
Zoetis (ZTS) Receives 'Equal-Weight' Rating from Barclays with a $136 Target | ZTS Stock News
Top 50 High-Quality Dividend Growth Stocks For December 2025
I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currentl...
Oversold Conditions For Zoetis (ZTS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
What's Driving the Market Sentiment Around Zoetis Inc?
Zoetis Inc's (NYSE: ZTS) short interest as a percent of float has fallen 25.5% since its last report. According to exchange reported data, there are now 8.25 million shares sold short , which is 1.87...
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment
Zoetis (ZTS) Gains Health Canada Approval for New Cat Osteoarthritis Treatment
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteo...
Zoetis Inc at Piper Sandler Healthcare Conference Transcript
Zoetis Inc at Piper Sandler Healthcare Conference Transcript